30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now

Julie McHugh

Track

Insider profile

Currently holds positions in Penwest Pharmaceuticals Co, Ironwood Pharmaceuticals Inc, Trevena Inc, Aerie Pharmaceuticals Inc and Lantheus Holdings Inc

Performance

Overall performance
0.9
Performance over holding periods
0.9
30 days 90 days 120 days
Average return -3% 8.2% 15.1%
Success rate 0% 68% 82%
Transactions
1 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance

Positions

Position Company Period
Director Penwest Pharmaceuticals Co Sept. 20, 2010 -
Independent Chairman of the Board Ironwood Pharmaceuticals Inc April 1, 2019 -
Independent Director Trevena Inc July 1, 2014 -
Independent Director Aerie Pharmaceuticals Inc June 29, 2015 -
Independent Director Lantheus Holdings Inc Jan. 25, 2017 -
Independent Director Ironwood Pharmaceuticals Inc Feb. 12, 2014 - April 1, 2019
Independent Director Shire Viropharma Inc Jan. 3, 2012 - Jan. 24, 2014
Julie McHugh's trades of Ironwood Pharmaceuticals Inc's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-06-16 2026-06-16
PrS Proposed sale
44,775
49.40
US$3,379,014 		44,775 49.40 US$3,379,014
2025-06-11 2025-06-09
PlS Planned sale
10,674 -33.4%
201.11
US$2,419,532 		10,674 -33.4% 201.11 US$2,419,532
2025-06-09 2025-06-09
PrS Proposed sale
9,580
426.73
US$4,114,679 		9,580 426.73 US$4,114,679
2024-06-12 2024-06-10
PlS Planned sale
22,766 -14.0%
6.29
US$143,198 		22,766 -14.0% 6.29 US$143,198
2024-06-10 2024-06-10
PrS Proposed sale
22,766
6.35
US$144,564 		22,766 6.35 US$144,564
2024-05-30 2024-05-28
PlS Planned sale
2,500 -8.0%
78.50
US$196,250 		2,500 -8.0% 78.50 US$196,250
2024-05-28 2024-05-28
PrS Proposed sale
2,500
78.50
US$196,250 		2,500 78.50 US$196,250
2022-09-08 2022-09-06
PlS Planned sale
4,300 -14.0%
78.50
US$337,550 		4,300 -14.0% 78.50 US$337,550
2022-05-13 2022-05-11
PlS Planned sale
2,980 -8.8%
57.84
US$172,363 		2,980 -8.8% 57.84 US$172,363
2022-03-16 2022-03-14
PlS Planned sale
20,000 -14.5%
11.67
US$233,400 		20,000 -14.5% 11.67 US$233,400
2021-12-16 2021-12-14
S Sale
10,000 -6.7%
11.02
US$110,200 		10,000 -6.7% 11.02 US$110,200
2021-04-13 2021-04-09
PlS Planned sale
2,800 -10.8%
21.22
US$59,416 		2,800 -10.8% 21.22 US$59,416
2020-09-09 2020-09-08
PlS Planned sale
7,950 -6.1%
9.77
US$77,672 		7,950 -6.1% 9.77 US$77,672
2020-03-02 2020-02-27
PlS Planned sale
1,756 -10.0%
15.86
US$27,845 		1,756 -10.0% 15.86 US$27,845
2019-06-07 2019-06-05
PlS Planned sale
1,500 -1.4%
11.26
US$16,890 		1,500 -1.4% 11.26 US$16,890
2019-03-08 2019-03-06
PlS Planned sale
2,595 -12.9%
22.77
US$59,075 		2,595 -12.9% 22.77 US$59,075
2019-03-06 2019-03-05
PlS Planned sale
1,500 -1.7%
14.38
US$21,570 		1,500 -1.7% 14.38 US$21,570
2018-12-10 2018-12-06
PlS Planned sale
1,500 -1.6%
12.46
US$18,690 		1,500 -1.6% 12.46 US$18,690
2018-03-06 2018-03-05
PlS Planned sale
1,500 -1.9%
14.06
US$21,090 		1,500 -1.9% 14.06 US$21,090
2017-12-06 2017-12-04
PlS Planned sale
1,500 -1.9%
16.45
US$24,675 		1,500 -1.9% 16.45 US$24,675